https://www.selleckchem.com/pr....oducts/homoharringto
lation, a reduced dose of rivaroxaban significantly decreased the composite outcome of fatal and nonfatal cardiovascular events and major bleeding complications compared with VKA. Oral Anticoagulation in Hemodialysis, NCT03799822. Oral Anticoagulation in Hemodialysis, NCT03799822.Clinical research is a discipline prone to the use of technical terms that may be particularly at risk for misunderstanding given the complex interpretation that is required. In this century, what is happening with the word 'pragmatic' when describing
Like
Comment
Share
